Position in ADMA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,704,842
-$19,422,695 QoQ
Shares Held
203,685
-91.3% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 323 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. ADMA ranks #117 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in ADMA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,704,842 | 203,685 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $21,127,537 | 2,344,899 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $50,959,932 | 2,793,856 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $41,607,174 | 2,838,143 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $49,513,279 | 2,719,016 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $32,413,201 | 1,633,730 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,608,237 | 327,011 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,351,200 | 167,644 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $1,570,387 | 140,464 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $778,067 | 117,889 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $433,567 | 95,922 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $343,400 | 95,922 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $371,616 | 100,709 | Shares | Defined | 2023-08-11 | |
| 2021-03-31 | $774,753 | 440,201 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,015,894 | 1,033,792 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,470,456 | 1,033,664 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,028,635 | 1,033,664 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,976,952 | 1,033,664 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||